Bharat Biotech's Nasal Covid Vaccine iNCOVACC launched on Republic Day, Health Minister said - this is proof of strong leadership
Union Health Minister Dr. Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's Nasal Covid Vaccine iNCOVACC, the world's first Nasal Vaccine against Corona.
Union Health Minister Dr. Mansukh Mandaviya and Science and Technology Minister Jitendra Singh have launched the Made-in-India iNCOVACC vaccine in the country's capital Delhi on the occasion of Republic Day. After which Union Health Minister Dr. Mansukh Mandaviya tweeted that "The world's first Covid Nasal Vaccine! Today, on the occasion of Republic Day, Minister Jitendra Singh, along with Dr. Krishna Ella and his team launched 'Nasal Vaccine'. This vaccine is An example of India's strength and potential. A testimony to Prime Minister Narendra Modi's strong leadership and commitment to a New India."
Along with this, he said in another tweet that "This is a historic achievement and a testimony to the innovative spirit of our scientists. It has made every Indian proud. Hearty congratulations to all our hardworking scientists and inventors who are working towards achieving the dream of a self-reliant India." working tirelessly to make it a reality."
Earlier, Bharat Biotech had announced in December last year that the intranasal vaccine would be sold at Rs 800 to private vaccination centers and Rs 325 per dose to the government. The special thing about this vaccine is that no needle will be used to apply it and it will be given through the nose. Bharat Biotech said in a statement that iNCOVACC is an adenovirus vectored vaccine. Clinical trials of this vaccine have been done in three phases, the results of which will be successful.
The iNCOVACC vaccine can also be booked through the Covin website. Two doses of the vaccine, 28 days apart, have been developed in partnership with Washington University St. Louis.